Cough, Cold & Allergy: Exploring the Current & Future Self-Care CCA Market
Reports Library Publication

Cough, Cold & Allergy: Exploring the Current & Future Self-Care CCA Market

30th October 2020 by Nicholas Hall Reports

Download Brochure

With global sales of over $29bn, the CCA market grew by 4.2% in 2019, just ahead of the global consumer healthcare market (+3.9%). The largest categories Systemic cold & flu and Cough remedies are mature, fragmented and hampered by safety concerns. Allergy remedies expanded via Rx-to-OTC switches in recent years but their impact may have peaked. Topical decongestants and Chest rubs & inhalants enjoyed the strongest performances in 2019.

But what is next for the CCA market? It is projected to be the fastest-growing category in 2020 (according to DB6 estimates), boosted by coronavirus and reports of a high incidence of seasonal cold & flu at the start of 2020, but as consumers in most countries filled their medicine chests in Q1, this may dampen demand for the rest of the year. Have lockdown and physical distancing measures reduced the incidence of flu, colds, and non-Covid viruses? The rest of the year remains unpredictable with a rapid return to normal or a second wave of Covid-19 distinct possibilities.

Order this report

The report features the latest sales data from our dedicated DB6 database, including topline historical sales by region, country and category, and individual brand performances. Sales cover 12 months to mid-year 2020 (and 2019), plus historical growth rates back to 2015. The latest short-term forecasts to 2020 & 2021 and longer-term forecasts to 2024 & 2029 for each market and category are included.

Cough, Cold & Allergy: Exploring the Current & Future Self-Care CCA Market

Why buy this report?

"Covering all the issues affecting the CCA market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this reports spans 10 in-depth country profiles (generating 70% of global sales between them) with insights and predictions. With a high degree of launch activity in CCA, new product developments are explored across markets, including Rx-to-OTC switches, delivery format innovations, new benefits and more."

Nicholas Hall

Contact us here

All personal data herein are processed in accordance with UK data protection legislation. All feasible security measures are in place.